series-a
Stage
1
Investors
About
Belhaven Biopharma is developing Nasdepi®, a dry powder, needle-free epinephrine nasal spray designed for rapid treatment of severe allergic reactions and anaphylaxis, aiming to improve accessibility and ease of use worldwide.
Explore Belhaven Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.